Pasvolsky, Oren
Wang, Zhongya
Milton, DenĂ¡i R.
Tanner, Mark R.
Bashir, Qaiser
Srour, Samer
Saini, Neeraj
Lin, Paul http://orcid.org/0000-0002-0524-267X
Ramdial, Jeremy
Nieto, Yago
Tang, Guilin http://orcid.org/0000-0002-9482-4806
Kebriaei, Partow
Aljawai, Yosra
Khan, Hina N.
Lee, Hans C. http://orcid.org/0000-0001-8545-3292
Ye, Christine
Patel, Krina K. http://orcid.org/0000-0002-8894-027X
Thomas, Sheeba K.
Orlowski, Robert Z.
Shpall, Elizabeth J.
Champlin, Richard E.
Qazilbash, Muzaffar H. http://orcid.org/0000-0003-2876-2886
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672, P30 CA016672)
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
U.S. Department of Health & Human Services | NIH | National Cancer Institute
Article History
Received: 11 March 2024
Revised: 23 April 2024
Accepted: 25 April 2024
First Online: 17 May 2024
Competing interests
: HCL reports consulting fees: Abbvie, Bristol Myers Squibb, Genentech, Janssen, Regeneneron, GlaxoSmithKline, Sanofi, Takeda Pharmaceuticals, Allogene Therapeutics; Research Funding: Amgen, Bristol Myers Squibb, Janssen, GlaxoSmithSkine, Regeneron, Takeda Pharmaceuticals. All other authors have not declared a conflict of interest.